These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 19744330)

  • 1. Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.
    Toussaint J; Sieuwerts AM; Haibe-Kains B; Desmedt C; Rouas G; Harris AL; Larsimont D; Piccart M; Foekens JA; Durbecq V; Sotiriou C
    BMC Genomics; 2009 Sep; 10():424. PubMed ID: 19744330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients.
    Harbeck N; Nimmrich I; Hartmann A; Ross JS; Cufer T; Grützmann R; Kristiansen G; Paradiso A; Hartmann O; Margossian A; Martens J; Schwope I; Lukas A; Müller V; Milde-Langosch K; Nährig J; Foekens J; Maier S; Schmitt M; Lesche R
    J Clin Oncol; 2008 Nov; 26(31):5036-42. PubMed ID: 18711169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Genomic Grade Assay Compared With Ki67 to Determine Risk of Distant Breast Cancer Recurrence.
    Ignatiadis M; Azim HA; Desmedt C; Veys I; Larsimont D; Salgado R; Lyng MB; Viale G; Leyland-Jones B; Giobbie-Hurder A; Kammler R; Dell'Orto P; Rothé F; Laïos I; Ditzel HJ; Regan MM; Piccart M; Michiels S; Sotiriou C
    JAMA Oncol; 2016 Feb; 2(2):217-24. PubMed ID: 26633571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of BrightGen HR RT-qDx assay to detect nuclear receptors mRNA overexpression in FFPE breast cancer tissue samples for selection of tamoxifen therapy.
    Wang HY; Park S; Kim S; Ahn S; Lee D; Kim S; Jung D; Park KH; Lee H
    Int J Clin Exp Pathol; 2014; 7(9):5792-800. PubMed ID: 25337220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agreement in breast cancer classification between microarray and quantitative reverse transcription PCR from fresh-frozen and formalin-fixed, paraffin-embedded tissues.
    Mullins M; Perreard L; Quackenbush JF; Gauthier N; Bayer S; Ellis M; Parker J; Perou CM; Szabo A; Bernard PS
    Clin Chem; 2007 Jul; 53(7):1273-9. PubMed ID: 17525107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of recurrence prediction ability of EndoPredict
    Watanabe A; Tsunashima R; Kato C; Kitano S; Matsumoto S; Sota Y; Morita M; Sakaguchi K; Naoi Y
    Breast Cancer; 2024 Jul; 31(4):593-606. PubMed ID: 38587783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of DNA microarray analyses using archival formalin-fixed paraffin-embedded breast cancer specimens.
    Sadi AM; Wang DY; Youngson BJ; Miller N; Boerner S; Done SJ; Leong WL
    BMC Cancer; 2011 Jun; 11():253:1-13. PubMed ID: 21679412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 72-gene classifier for predicting prognosis of estrogen receptor-positive and node-negative breast cancer patients using formalin-fixed, paraffin-embedded tumor tissues.
    Nishio M; Naoi Y; Tsunashima R; Nakauchi C; Kagara N; Shimoda M; Shimomura A; Maruyama N; Shimazu K; Kim SJ; Noguchi S
    Clin Breast Cancer; 2014 Jun; 14(3):e73-80. PubMed ID: 24461457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.
    Esteva FJ; Sahin AA; Cristofanilli M; Coombes K; Lee SJ; Baker J; Cronin M; Walker M; Watson D; Shak S; Hortobagyi GN
    Clin Cancer Res; 2005 May; 11(9):3315-9. PubMed ID: 15867229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 3-gene proliferation score (TOP-FOX-67) can re-classify histological grade-2, ER-positive breast cancers into low- and high-risk prognostic categories.
    Szekely B; Iwamoto T; Szasz AM; Qi Y; Matsuoka J; Symmans WF; Tokes AM; Kulka J; Swanton C; Pusztai L
    Breast Cancer Res Treat; 2013 Apr; 138(3):691-8. PubMed ID: 23504136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of Ki67 gene expression analysis using formalin-fixed paraffin-embedded breast cancer specimens.
    Yamamoto S; Ibusuki M; Yamamoto Y; Fu P; Fujiwara S; Murakami K; Iwase H
    Breast Cancer; 2013 Jul; 20(3):262-70. PubMed ID: 22362219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of gene expression profiling by reverse transcription quantitative PCR between fresh frozen and formalin-fixed, paraffin-embedded breast cancer tissues.
    Sánchez-Navarro I; Gámez-Pozo A; González-Barón M; Pinto-Marín A; Hardisson D; López R; Madero R; Cejas P; Mendiola M; Espinosa E; Vara JA
    Biotechniques; 2010 May; 48(5):389-97. PubMed ID: 20569212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of gene expression profiles predicting progression in breast cancer patients treated with tamoxifen.
    Kok M; Linn SC; Van Laar RK; Jansen MP; van den Berg TM; Delahaye LJ; Glas AM; Peterse JL; Hauptmann M; Foekens JA; Klijn JG; Wessels LF; Van't Veer LJ; Berns EM
    Breast Cancer Res Treat; 2009 Jan; 113(2):275-83. PubMed ID: 18311582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.
    Andersen J
    Acta Oncol; 1992; 31(6):611-27. PubMed ID: 1281648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer.
    Nielsen TO; Parker JS; Leung S; Voduc D; Ebbert M; Vickery T; Davies SR; Snider J; Stijleman IJ; Reed J; Cheang MC; Mardis ER; Perou CM; Bernard PS; Ellis MJ
    Clin Cancer Res; 2010 Nov; 16(21):5222-32. PubMed ID: 20837693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of prognostic and predictive impact of genomic or central grade and immunohistochemical subtypes or IHC4 in HR+/HER2- early breast cancer: WSG-AGO EC-Doc Trial.
    Gluz O; Liedtke C; Huober J; Peyro-Saint-Paul H; Kates RE; Kreipe HH; Hartmann A; Pelz E; Erber R; Mohrmann S; Möbus V; Augustin D; Hoffmann G; Thomssen C; Jänicke F; Kiechle M; Wallwiener D; Kuhn W; Nitz U; Harbeck N
    Ann Oncol; 2016 Jun; 27(6):1035-1040. PubMed ID: 27022068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression variation between distinct areas of breast cancer measured from paraffin-embedded tissue cores.
    Schobesberger M; Baltzer A; Oberli A; Kappeler A; Gugger M; Burger H; Jaggi R
    BMC Cancer; 2008 Nov; 8():343. PubMed ID: 19032762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of prognostic gene profiles using qRT-PCR in paraffin samples: a retrospective study in patients with early breast cancer.
    Espinosa E; Sánchez-Navarro I; Gámez-Pozo A; Marin AP; Hardisson D; Madero R; Redondo A; Zamora P; San José Valiente B; Mendiola M; González Barón M; Fresno Vara JA
    PLoS One; 2009 Jun; 4(6):e5911. PubMed ID: 19547727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of RNA-FISH Assay for Detection of Oncogenic FGFR3-TACC3 Fusion Genes in FFPE Samples.
    Kurobe M; Kojima T; Nishimura K; Kandori S; Kawahara T; Yoshino T; Ueno S; Iizumi Y; Mitsuzuka K; Arai Y; Tsuruta H; Habuchi T; Kobayashi T; Matsui Y; Ogawa O; Sugimoto M; Kakehi Y; Nagumo Y; Tsutsumi M; Oikawa T; Kikuchi K; Nishiyama H
    PLoS One; 2016; 11(12):e0165109. PubMed ID: 27930669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative determination of insulin-like growth factor 1 receptor mRNA in formalin-fixed paraffin-embedded tissues of invasive breast cancer.
    Fu P; Ibusuki M; Yamamoto Y; Yamamoto S; Fujiwara S; Murakami K; Zheng S; Iwase H
    Breast Cancer; 2012 Oct; 19(4):321-8. PubMed ID: 21990036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.